| Upregulated A7 vs Control |
| Up regulated genes in neural crest development of melanocytes, differentiation and pigmentation and down regulated genes in angiogenesis, neurogenesis, immunomodulation and interaction and remodeling extracellular environment |
39/65 |
0 |
Jeffs et al., 2009 |
| Genes downregulated in aggressive melanoma cells |
24/60 |
0 |
Ryu et al., 2007 |
| Genes with low expression in metastatic melanomas vs melanocytes |
8/23 |
0 |
Riker et al., 2008 |
| Genes with low expression in primary cutaneous melanomas vs melanocytes |
12/21 |
0 |
Riker et al., 2008 |
| Genes downregulated in metastatic vs primary melanomas |
6/38 |
0,036 |
Jaeger et al., 2007 |
| Downregulated in A7 vs Control |
| Genes upregulated in positive metastatic melanoma |
69/183 |
0 |
Winnepenninckx et al., 2006 |
| Genes upregulated in vertical vs radial growth melanomas |
26/48 |
0 |
Ryu et al., 2007 |
| Genes downregulated in melanomas with low proliferative and high metastatic capacity |
4/5 |
0,002 |
Hoek et al., 2006 |
| Genes upregulated in melanomas with low proliferative and high metastatic capacity |
4/5 |
0,004 |
Hoek et al., 2006 |
| Upregulated in G10 vs Control |
| Prolonged survival |
9/50 |
0 |
Bogunovic et al., 2009 |
| Genes upregulated in MGP melanoma cells vs melanocytes |
10/29 |
0 |
Pfaff Smith et al., 2005 |
| Down regulated genes in neural crest, melanocyte development, differentiation and pigmentation and up regulated genes in angiogenesis, neurogenesis, immunomodulation and interaction and remodeling of extracellular environment |
12/31 |
0,008 |
Jeffs et al.,2009 |
| Genes upregulated in melanomas with low proliferative and high metastatic capacity |
3/5 |
0,008 |
Hoek et al., 2006 |
| Genes downregulated in melanomas with low proliferative capacity and high metastatic capacity |
2/5 |
0,008 |
Hoek et al., 2006 |
| Genes upregulated in vertical vs radial growth melanomas |
13/48 |
0,012 |
Ryu et al.,2007 |
| Downregulated in G10 vs Control |
| Genes downregulated in metastatic melanomas vs primary melanomas |
4/17 |
0 |
Jaeger et al., 2007 |
| Molecular signature of metastatic melanomas |
3/11 |
0,016 |
Wang et al., 2012 |
